ANNE TAFEL: Open Payments
NPI 1609548171 · LEXINGTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$972 in 54 payments from 14 companies in 2025. Trend: 2023 $207 · 2024 $406 · 2025 $972
Food & beverage: $972
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $188 |
| ABBVIE INC. | 12 | $155 |
| PFIZER INC. | 6 | $133 |
| Novo Nordisk Inc | 6 | $109 |
| Lilly USA, LLC | 4 | $61 |
| Edwards Lifesciences Corporation | 2 | $59 |
| Exact Sciences Corporation | 3 | $53 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Merck Sharp & Dohme LLC | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
Products named: AIRSUPRA, NURTEC ODT, QULIPTA, MOUNJARO, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), Wegovy, Ozempic, Cologuard Collection Kit.
Industry payments across SC — which companies pay providers there.
